Brandon Capital is Australasia's leading life science venture capital firm, investing in biomedical breakthroughs from early-stage seed through to expansion capital. Headquartered in Melbourne with offices in Sydney, San Francisco, and London, the firm manages over A$1 billion across six funds.
72% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (2 deals in the last 12 months vs 3 prior). Average disclosed round size is $54.2M (across 32 rounds with reported amounts).
Portfolio
28
Fund Size
$290M
Top Stage
Series B
Last 12 Mo
2
Team
Chris Smith
Partner
David Fisher
Partner Emeritus
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
46 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Lumonus | Series B | — | Mar 2026 |
| OOncoRes Medical | Unknown | — | Feb 2026 |
| EEna Respiratory | Series B | $22.4M | Oct 2025 |
 NRG Therapeutics | Series B | $50M | Sep 2025 |
 Allay Therapeutics | Series D | $57.5M | Jun 2025 |
| PPolyActiva | Series C | — | May 2025 |
| MMirugen | Seed | $4.5M | Jan 2025 |
 Allay | Series D | $57.5M | Jan 2025 |
 Catalym | Series D | $150M | Jul 2024 |
 Pheon Therapeutics | Series B | $120M | May 2024 |
 Pathios Therapeutics | Series B | $25M | Apr 2024 |
 Entact Bio | Series A | $81M | Dec 2022 |
 Entact | Series A | $81M | Dec 2022 |
| Catalym | Series C | — | Nov 2022 |
| NRG Therapeutics | Series A | — | Nov 2022 |
| Pheon Therapeutics | Series A | $68M | Sep 2022 |
| Pheon Therapeutics | Series A | $68M | Mar 2022 |
 Aravax | Series B | $42.2M | Jan 2022 |
 Tessa | Series A | $200M | Jan 2022 |
| Catalym | Series C | — | Jan 2022 |
| Entact Bio | Series A | $81M | Jan 2022 |
| EEna Respiratory | Unknown | — | Jun 2021 |
| EEna Respiratory | Series B | — | Jan 2021 |
| AAmaroq Therapeutics | Unknown | $14M | Jan 2021 |
| GGeorge Medicine | Unknown | $20M | Jan 2020 |
Page 1 of 2
Top Co-Investors
Canaan Partners10 shared
Forbion6 shared
UniQuest6 shared
Abingworth LLP5 shared
Atlas Venture4 shared
Tenmile4 shared
Novartis Venture Fund4 shared
Lightspeed Venture Partners3 shared
Sanofi Ventures3 shared
SV Health Investors3 shared
Omega Funds3 shared
EDBI3 shared
venBio3 shared
4BIO Capital3 shared
Qiming Venture Partners USA3 shared
Logos Capital3 shared
Arkin Bio Ventures3 shared
Surveyor Capital3 shared
Jeito Capital3 shared
Last updated: 20 October 2026